APLASTIC ANEMIA

This early-stage trial is testing whether adding specially treated immune cells, called 'veto cells,' can help patients with blood cancers or bone marrow failure after a stem cell transplant. The goal is to help the donor's cells grow in the patient's body without causing a dange…

This study aims to confirm the safety of the drug ATGAM for patients in Japan who have moderate to severe aplastic anemia, a rare condition where the body stops producing enough new blood cells. It will observe a small group of patients for 6 months to monitor for any side effect…

This study is testing a personalized plan to manage cytomegalovirus (CMV), a common and potentially serious infection, in patients who have received a donor stem cell transplant for blood cancers or disorders. The plan involves closely monitoring the virus level and the patient's…

This study is testing a new, gentler bone marrow transplant procedure for people with dyskeratosis congenita, a rare genetic disorder that causes bone marrow failure. The standard transplant uses harsh drugs and radiation that can worsen lung/liver disease and cancer risk in thes…

This study aims to see if adding methadone to standard morphine pain medication better controls severe mouth pain in children aged 6-18 undergoing stem cell transplants. Researchers will compare pain levels, medication use, and recovery between children receiving the two-drug com…

This study is observing patients for up to 5 years after they completed a previous clinical trial for aplastic anemia. The goal is to understand the long-term safety and effectiveness of the drug romiplostim. Researchers will track blood counts, the need for transfusions, and che…